BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1207 related articles for article (PubMed ID: 25730946)

  • 1. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lessons learned from tuberculosis outbreak cases].
    Kato S; Kuwabara K
    Kekkaku; 2014 Feb; 89(2):77-88. PubMed ID: 24716362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
    Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
    Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.
    Vinton P; Mihrshahi S; Johnson P; Jenkin GA; Jolley D; Biggs BA
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):215-21. PubMed ID: 19191484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interpreting "equivocal" results obtained from the QuantiFERON-TB Gold In-Tube test in contact investigations].
    Komukai J; Matsumoto K; Hirota S; Yoshida H; Koda S; Terakawa K; Shimouchi A
    Kekkaku; 2013 Mar; 88(3):301-4. PubMed ID: 23672171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tuberculin skin testing and QuantiFERON-TB Gold-In Tube test in health care workers.
    Cağlayan V; Ak O; Dabak G; Damadoğlu E; Ketenci B; Ozdemir M; Ozer S; Saygı A
    Tuberk Toraks; 2011; 59(1):43-7. PubMed ID: 21554229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results.
    Seyhoglu E; Uyaroğlu OA; Erden A; Kilic L; Karadag O; Akdogan A; Bilgen SA; Ertenli I; Kiraz S; Kalyoncu U
    Clin Rheumatol; 2021 May; 40(5):2027-2035. PubMed ID: 33057917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the QuantiFERON-TB blood assay a good replacement for the tuberculin skin test in tuberculosis screening? a pilot study at Berkshire Medical Center.
    Zhao X; Mazlagic D; Flynn EA; Hernandez H; Abbott CL
    Am J Clin Pathol; 2009 Nov; 132(5):678-86. PubMed ID: 19846807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.
    Rutherford ME; Nataprawira M; Yulita I; Apriani L; Maharani W; van Crevel R; Hill PC; Alisjahbana B
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):496-502. PubMed ID: 22325792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana.
    Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D
    Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of Quantiferon-TB Gold and tuberculin skin test in patients with tuberculosis, close contact of patients, health care workers and tuberculosis laboratory personnel].
    Cesur S; Hoca NT; Tarhan G; Cimen F; Ceyhan I; Annakkaya AN; Aslan T; Birengel S
    Mikrobiyol Bul; 2010 Oct; 44(4):553-60. PubMed ID: 21063967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts.
    Arend SM; Thijsen SF; Leyten EM; Bouwman JJ; Franken WP; Koster BF; Cobelens FG; van Houte AJ; Bossink AW
    Am J Respir Crit Care Med; 2007 Mar; 175(6):618-27. PubMed ID: 17170386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.